The UK Coronavirus Cancer Monitoring Project: protecting patients with cancer in the era of COVID-19
Cet article discute des enjeux liés à la prise en charge des patients atteints d’un cancer pendant la crise sanitaire liée au COVID-19 au Royaume-Uni
The UK Coronavirus Cancer Monitoring Project (UKCCMP) aims to collect, analyse, and disseminate in real time data from the UK cancer centres about severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection rates in patients with cancer, and their outcomes in terms of coronavirus disease 2019 (COVID-19). This approach will enable oncologists to gain crucial insights to inform decision making.In December, 2019, several cases of acute respiratory syndrome in Hubei province, China were identified; these were the first described cases of COVID-19. The causative virus, SARS-CoV-2, is a new strain of betacoronavirus previously not identified in humans and thought to be of zoonotic origin.1 The presentation of COVID-19 varies from no or minor symptoms akin to the common cold, to severe acute respiratory distress syndrome, resulting in severely impaired respiratory function.1 SARS-CoV-2 is highly contagious through direct transfer of respiratory droplets during coughing and sneezing or indirect fomite spread via contaminated surfaces.2 This simple transmission, coupled with international travel, has enabled rapid spread of the virus with more than 870?000 cases and 43?000 deaths reported worldwide as of April 1, 2020..(…)